High dose-rate tandem and ovoid brachytherapy in cervical cancer: dosimetric predictors of adverse e...
High dose-rate tandem and ovoid brachytherapy in cervical cancer: dosimetric predictors of adverse events
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Brachytherapy (BT) is a vital component of the curative treatment of locally advanced cervical cancer. The American Brachytherapy Society has published guidelines for high dose rate (HDR) BT with recommended dose limits. However, recent reports suggest lower doses may be needed to avoid toxicity. The purpose of this study is to investigate incidenc...
Alternative Titles
Full title
High dose-rate tandem and ovoid brachytherapy in cervical cancer: dosimetric predictors of adverse events
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_3447f6264cea47de928f4a70ddb37266
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3447f6264cea47de928f4a70ddb37266
Other Identifiers
ISSN
1748-717X
E-ISSN
1748-717X
DOI
10.1186/s13014-018-1074-2
